Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS- related cryptococcosis

International Journal of STD and AIDS

Volumn 8, Issue 6, 1997, Pages 406-408

  Manfredi, Roberto ^a   Coronado, Olga V ^a   Mastroianni, Antonio ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cryptococcosis; HIV AIDS; liposomal amphotericin B; paediatric; rHuGM CSF

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; DIDANOSINE; FLUCONAZOLE; IMMUNOGLOBULIN; ITRACONAZOLE; PENTAMIDINE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DOSE RESPONSE; DRUG FORMULATION; DRUG MIXTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CHILD; CRYPTOCOCCOSIS; DRUG CARRIERS; DRUG THERAPY, COMBINATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LIPOSOMES; RECOMBINANT PROTEINS;

EID: 0030908236     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971920226     Document Type: Article

References (27)

1. Hay RJ. Clinical manifestations and management of cryptococcosis in the compromised patient. In: Warnock DW, Richardson MD, eds. Fungal Infections in the Compromised Patient, 2nd edn. Chichester: John Wiley & Sons, 1991:85-115
2. Rozenbaum R, Gonçalves AJR. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994;18:369-80
3. Turner BJ, Denison M, Eppes SC, Houchens R, Fanning T, Markson LE. Survival experience of 789 children with the acquired immunodeficiency syndrome. Pediatr Infect Dis J 1993;12:310-20
4. The European Collaborative Study. Natural history of vertically acquired immunodeficiency virus-1 infection. Pediatrics 1994;94:815-19
5. Leggiadro RJ, Kline MW, Hughes WT. Extrapulmonary cryptococcosis in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1991;10:658-62
6. Dismukes WE. Management of cryptococcosis. Clin Infect Dis 1993;17(suppl 2):507-12
7. Ellis D, Pfeiffer T. The ecology of Cryptococcus neoformans. Eur J Epidemiol 1992;8:321-5
8. Pippard MJ, Dalgleish A, Gibson P, Malkovsky M, Webster ADB. Acquired immunodeficiency with disseminated cryptococcosis. Arch Dis Child 1986;61:289-302
9. Jimenez-Acosta F, Casado M, Borbujo J, Soto-Melo J, Viguer JM, Sanjurio MJ. Cutaneous cryptococcosis mimicking molluscum contagiosum in a haemophiliac with AIDS. Clin Exp Dermatol 1987;12:446-50
10. Ting SF, Glader BE, Prober CG. Cryptococcus infection in a nine-year-old child with hemophilia and the acquired immunodeficiency syndrome. Pediatr Infect Dis J 1991;10:76-7
11. Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990;113:183-7
12. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, the NIAID Mycosis Study Group and the AIDS Clinical Trial Group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9
13. Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, the NIAID Mycosis Study Group and the AIDS Clinical Trial Group. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:793-8
14. De Gans J, Portegies P, Tiessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6: 185-90
15. Nelson MR, Fisher M, Cartledge J, Rogers T, Gazzard BG. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS 1994;8: 651-4
16. Larsen RA, Bozzette SA, Jones BE, et al. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994;19:741-5
17. Manfredi R, Mastroianni A, Coronado OV, Chiodo F. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection. Arch Intern Med 1997;157:64-9
18. Hay RJ. Liposomal amphotericin B, AmBisome. J Infect 1994;28(suppl 1):35-43
19. Ng TT, Denning DW. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data. Arch Intern Med 1995;155:1093-8
20. Schürmann D, De Matos Marques D, Grünewald T, Pohle HD, Hahn H, Ruf B. Safety and efficacy of liposomal amphotericin B in treating AIDS-associated disseminated cryptococcosis. J Infect Dis 1991;164:620-2
21. Coker RJ, Viviani M, Gazzard BG, et al. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 1993;7:829-35
22. Ringden O, Tollemar J. Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children. Mycoses 1993;36:187-92
23. Freund M, Kleine HD. The role of GM-CSF in infection. Infection 1992;20(suppl 2):84-92
24. Bodey GP. The potential role of granulocyte-macrophage colony-stimulating factor in therapy of fungal infections: a commentary. Eur J Clin Microbiol Infect Dis 1993;13:363-6
25. Smith PD, Lamerson CD, Banks SM, et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis 1990;161:999-1005
26. Kowanko IC, Ferrante A, Harvey DP, Carman KL. Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation. Clin Exp Immunol 1991;83:225-30
27. Chen GH, Curtis JL, Mody CH, Christensen PJ, Armstrong LR, Toews GB. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol 1994;152:724-34